Total tubeless PCNL game-changer for post-op pain management and efficiency in kidney stone treatment, highlights study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-07-01 02:30 GMT   |   Update On 2024-07-01 02:31 GMT
Advertisement

Turkey: Percutaneous nephrolithotomy (PCNL) is a well-established procedure for treating kidney stones, but recent advancements have sparked debate over the best approach. A new study comparing standard PCNL with total tubeless PCNL performed in the supine position offers fresh insights into these techniques.

The study revealed that total tubeless (TT) percutaneous nephrolithotomy in the supine position reduces postoperative pain in selected patients without affecting the complication rates as in prone PCNL. According to the authors, the study was the first to compare TT and standard PCNL in the supine position," the researchers wrote. The findings were published online in Urolithiasis on June 04, 2024.

Advertisement

Both techniques delivered similar complication and stone-free rates, however, TT PCNL boasted shorter fluoroscopy & operation times. Most notably, TT PCNL emerged as a game-changer for postoperative pain management, significantly reducing visual analog scale scores.

The debate over which method provides superior outcomes continues to evolve, with proponents of each technique advocating based on their respective advantages. While standard PCNL remains a cornerstone in kidney stone treatment, total tubeless PCNL in the supine position presents a compelling alternative for selected patients seeking faster recovery and reduced postoperative complications.

Çağdaş Bildirici, Department of Urology, Bitlis State Hospital, Bitlis, Turkey, and colleagues aimed to compare the safety, efficacy, and advantages of the total tubeless percutaneous nephrolithotomy and standard PCNL in the supine position.

In the study carried out at İzmir Tepecik Health Application and Research Center, 87 patients were examined. Forty-three patients who underwent the TT procedure were defined as Group 1, and 44 patients who underwent the standard procedure with a nephrostomy tube were defined as Group 2.

Two techniques were evaluated with outcome parameters and demographic data. Univariate regression analyses were conducted in these data sets for the parameters that predicted the TT procedure.

The study revealed the following findings:

· The demographic data of the groups and all characteristics of the stones were similar.

· When the results were examined, the stone-free rates detected by non-contrast computed tomography (CT) in the postoperative 1st month were similar between the groups.

· Complication rates and secondary intervention rates were similar.

· Operation and fluoroscopy times were shorter in group 1, which were not statistically significant.

· Postoperative hemoglobin decreased, and creatinine values were similar.

· In Group 1, mean postoperative visual analog scale (VAS) scores and the percentage of VAS reporting > 5 points for pain level measurement were lower and statistically significant.

· In the univariate analysis of the factors predicting the TT procedure, no significant results were found in any parameter.

In conclusion, while both standard and total tubeless PCNL techniques have proven efficacy in treating kidney stones, the choice between them hinges on a nuanced understanding of patient factors and desired outcomes. This study marks a step forward in clarifying the comparative benefits of these procedures, paving the way for informed decision-making in clinical practice.

Reference:

Bildirici, Ç., Çetin, T., Yalçın, M.Y. et al. Comparison of standard percutaneous nephrolithotomy and total tubeless percutaneous nephrolithotomy in the supine position. Urolithiasis 52, 82 (2024). https://doi.org/10.1007/s00240-024-01580-5


Tags:    
Article Source : Urolithiasis Journal

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News